Ethyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate

Catalog No. :
ACFJHR864
CAS No. :
40277-49-4
Molecular Formula :
C14H16N2O3S
Molecular Weight :
292.36

IUPAC Name:ethyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate

Ethyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$515.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate
IUPAC Nameethyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate
Molecular FormulaC14H16N2O3S
Molecular Weight292.36
SMILESO=C(OCC)CN(C=NC1=C2C3=C(CCCC3)S1)C2=O
InChI KeyABRJMUYLUUBNTB-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB009545;AKOS B020907;(4-OXO-5,6,7,8-TETRAHYDRO-4 H-BENZO[4,5]THIENO[2,3-D ]PYRIMIDIN-3-YL)-ACETIC ACID ETHYL ESTER;ART-CHEM-BB B020907;AURORA 20197;BUTTPARK 128\48-22;Ethyl 2-(4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)acetate;[1]Benzothieno[2,3-d]pyrimidine-3(4H)-acetic acid, 5,6,7,8-tetrahydro-4-oxo-, ethyl ester
CAS No.40277-49-4

Synthetic Route by SureRoute

1. ACFJHR864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRNU936 route compound structure diagram
    ACTRNU93614346-24-8 In Stock
  4. Then
  5. ACFJHR864 route product structure diagram
    ACFJHR86440277-49-4
Inquiry

2. ACFJHR864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRNU936 route compound structure diagram
    ACTRNU93614346-24-8 In Stock
  4. Then
  5. ACFJHR864 route product structure diagram
    ACFJHR86440277-49-4
Inquiry

Comments (0)